Abstract
A comparative study of acute lesions in multiple sclerosis patients and in marmosets suggests that anti–MOG antibodies are responsible for the demyelination characteristic of this autoimmune disease (170–175).
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Genain, C.P. et al. In healthy primates, circulating autoreactive T cells mediate autoimmune disease. J.Clin.Invest. 94, 1339–1345 (1994).
Meinl, E. et al. Encephalitogenic potential of myelin basic protein–specific T cells isolated from normal rhesus macaques. Am.J.Pathol. 150, 445–453 (1997).
Steinman, L. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system. Cell 85, 299– 302 (1996).
Lassmann, H., Raine, C.S., Antel, J. & Prineas, J.W. Immunopathology of multiple sclerosis: Report on an international meeting held at the Institute of Neurology, University of Vienna. J.Neuroimmunol. 86, 213–217 (1998).
Genain, C.P., Cannella, B. Hauser, S.L. & Raine, C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nature Med. 5, 170– 175 (1999).
Bernard, C.C.A. et al. Myelin oligodendrocyte glycoprotein: A novel candidate autoantigen in multiple sclerosis. J.Mol.Med. 75, 77–88 (1997).
Storch, M.K. et al. Autoimmunity to myelin oligodendrocyte glycoprotein in rats mimics the spectrum of multiple sclerosis pathology. Brain Pathol. 8, 681–694 (1998) .
Kerlero de Rosbo, N. et al. Reactivity to myelin antigens in multiple sclerosis. J.Clin.Invest. 92, 2602–2608 (1993).
Wallström, E. et al. Increased reactivity to myelin oligodendrocyte glycoprotein peptides and epitope mapping in HLA DR2 (15)+ positive multiple sclerosis. Eur.J.Immunol. 28, 3329– 3335 (1998).
Bieganowska, K.D. et al. Direct ex vivo evidence of activated, Fas–sensitive autoreactive T cells in human autoimmune disease. J.Exp.Med. 185, 1585–1594 (1997).
Genain, C.P. et al. Antibody facilitation of multiple sclerosis–like lesions in a nonhuman primate. J.Clin.Invest. 96, 2966–2974 (1995).
Linington, C., Bradl, M., Lassmann, H., Brunner, C. & Vass, K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am.J.Pathol. 130, 443– 454 (1988).
Esiri, M.M. Multiple sclerosis: A quantitative and qualitative study of immunoglobulin–containing cells in the central nervous system. Neuropathol. Appl. Neurobiol. 6, 9–21 (1980).
Litzenburger, T. et al. B lymphocytes producing demyelinating autoantibodies: Development and function in gene–targeted transgenic mice. J.Exp.Med. 188, 169–180 (1998).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Wekerle, H. Remembering MOG: Autoantibody mediated demyelination in multiple sclerosis? . Nat Med 5, 153–154 (1999). https://doi.org/10.1038/5514
Issue Date:
DOI: https://doi.org/10.1038/5514
This article is cited by
-
Cannabinoids Decrease the Th17 Inflammatory Autoimmune Phenotype
Journal of Neuroimmune Pharmacology (2013)
-
Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis
Nature Biotechnology (2003)